Ignite Creation Date:
2025-12-24 @ 12:51 PM
Ignite Modification Date:
2026-02-23 @ 4:55 AM
Study NCT ID:
NCT04677361
Status:
WITHDRAWN
Last Update Posted:
2021-10-08
First Post:
2020-12-17
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Feasibility Study on Expandion of MILs From NSCLC and SCLC Patients and Infusion With Pembrolizumab
Sponsor:
Fox Chase Cancer Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-10
Start Date Type:
ESTIMATED
Primary Completion Date:
2023-10
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-10
Completion Date Type:
ESTIMATED
First Submit Date:
2020-12-17
First Submit QC Date:
None
Study First Post Date:
2020-12-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-10-01
Last Update Post Date:
2021-10-08
Last Update Post Date Type:
ACTUAL